Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on Repligen, Raises Price Target to $260

Keybanc analyst Paul Knight maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $245 to $260.
byBenzinga Newsdesk
August 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Keybanc analyst Paul Knight maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $245 to $260.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

US Stock Futures Signal Higher Start On Wall Street; Bank of America Earnings In Focus

By Lisa Levin
October 17, 6:00 AM
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Monday after closing lower in the previous session. The Dow Jones dropped by more than 400 points in the previous session, while the Nasdaq tumbled over 300 points. For the week, the Dow added 1.15%, while the S&P 500 declined around 1.6%.

AAPL